FACS analysis on the peripheral blood of the mice with anti-human CD3 antibody showed that GIFT4-treated CLL cells increased human T cell number in peripheral blood in comparison with GM-CSF and IL-4 or PBS control treatment (Fig. 5a). The gene discussed is CSF2; the disease is B-cell chronic lymphocytic leukemia.